Poly(ADP-ribose) polymerase activation and cell injury in the course of rat heart heterotopic transplantation

被引:20
作者
Fiorillo, C
Pace, S
Ponziani, V
Nediani, C
Perna, AM
Liguori, P
Cecchi, C
Nassi, N
Donzelli, GP
Formigli, L
Nassi, P
机构
[1] Univ Florence, Dept Sci Biochim, I-50134 Florence, Italy
[2] Azienda Osped Careggi, Div Cardiochirurg, Florence, Italy
[3] Univ Florence, Dipartimento Pediat, I-50132 Florence, Italy
[4] Univ Florence, Dipartimento Anat Istol & Med Legale, I-50134 Florence, Italy
关键词
PARP; heart; ischemia; reperfusion; necrosis; apoptosis;
D O I
10.1080/10715760210168
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Free radicals and other reactive species generated during reperfusion of ischemic tissues may cause DNA damage and, consequently, the activation of the nuclear enzyme poly(ADP-ribose) polymerase (PARP). An excessive PARP activation may result in a depletion of intracellular NAD(+) and ATP, hence cell suffering and, ultimately, cell death. The present study is aimed at clarifying the role of PARP in a heart transplantation procedure and the contribution of myocyte necrosis and/or apoptosis to this process. In our experimental model, rat heart subjected to heterotopic transplantation, low temperature global ischemia (2 h) was followed by an in vivo reperfusion (30 or 60 min). Under these conditions clear signs of oxidative stress, such as lipoperoxidation and DNA strand breaks, were evident. In addition to a marked activation, accompanied by a significant NAD(+) and ATP depletion, PARP protein levels significantly increased after 60 min of reperfusion. Ultrastructural analysis showed nuclear clearings, intracellular oedema and plasma membrane discontinuity. Other relevant observations were the absence of typical signs of apoptosis like caspase-3 activation and PARP cleavage, random DNA fragmentation, rise in serum levels of heart damage markers. Our results suggest that during heart transplantation, the activation of PARP, causing energy depletion, results in myocardial cell injury whose dominant feature, at least in our experimental model, is necrosis rather than apoptosis.
引用
收藏
页码:79 / 87
页数:9
相关论文
共 50 条
  • [31] Poly (ADP-Ribose) Polymerase Inhibitors as Potential Therapeutic Agents in Stroke and Neurotrauma
    Komjati, Katalin
    Besson, Valerie C.
    Szabo, Csaba
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2005, 4 (02) : 179 - 194
  • [32] Activation of poly(ADP-ribose) polymerase in circulating leukocytes during myocardial infarction
    Murthy, KGK
    Xiao, CY
    Mabley, JG
    Chen, M
    Szabó, C
    SHOCK, 2004, 21 (03): : 230 - 234
  • [33] Protective effects of caspase-9 and poly(ADP-ribose) polymerase inhibitors on ischemia-reperfusion-induced myocardial injury
    Sodhi, Rupinder K.
    Singh, Manjeet
    Singh, Nirmal
    Jaggi, Amteshwar S.
    ARCHIVES OF PHARMACAL RESEARCH, 2009, 32 (07) : 1037 - 1043
  • [34] Poly(ADP-ribose) activation in circulating cells in human myocardial infarction
    Szabo, Csaba
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2009, 132 (02) : 273 - 274
  • [35] Pharmacologic inhibition of poly(ADP-ribose) polymerase is neuroprotective following traumatic brain injury in rats
    LaPlaca, MC
    Zhang, J
    Raghupathi, R
    Li, JH
    Smith, F
    Bareyre, FM
    Snyder, SH
    Graham, DI
    McIntosh, TK
    JOURNAL OF NEUROTRAUMA, 2001, 18 (04) : 369 - 376
  • [36] Poly(ADP-ribose) polymerase localizes to the centrosomes and chromosomes
    Kanai, M
    Uchida, M
    Hanai, S
    Uematsu, N
    Uchida, K
    Miwa, M
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 278 (02) : 385 - 389
  • [37] Cardioprotective effects of poly (ADP-ribose) polymerase inhibition
    Szabó, C
    PHARMACOLOGICAL RESEARCH, 2005, 52 (01) : 34 - 43
  • [38] Poly(ADP-ribose)polymerase inhibition decreases angiogenesis
    Rajesh, Mohanraj
    Mukhopadhyay, Partha
    Godlewski, Grzegorz
    Batkai, Sandor
    Hasko, Gyorgy
    Liaudet, Lucas
    Pacher, Pal
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 350 (04) : 1056 - 1062
  • [39] Functions of the poly(ADP-ribose) polymerase superfamily in plants
    Rebecca S. Lamb
    Matteo Citarelli
    Sachin Teotia
    Cellular and Molecular Life Sciences, 2012, 69 : 175 - 189
  • [40] Poly (ADP-ribose) Polymerase Inhibitors in Cancer Treatment
    Mason, Kathryn A.
    Raju, Uma
    Buchholz, Thomas A.
    Wang, Li
    Milas, Zvonimir L.
    Milas, Luka
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2014, 37 (01): : 90 - 100